INCLUDE (INvestigation of Co-occurring conditions across the Lifespan to Understand Down syndromE) Predoctoral to Postdoctoral Fellow Transition Award (F99/K00 Clinical Trial Not Allowed)
ID: 352577Type: Posted
Overview

Buyer

National Institutes of Health (HHS-NIH11)

Eligible Applicants

Others

Funding Category

Income Security and Social Services

Funding Instrument

Grant

Opportunity Category

Discretionary

Cost Sharing or Matching Requirement

Yes
Timeline
    Description

    The National Institutes of Health (NIH) is offering the INCLUDE (INvestigation of Co-occurring conditions across the Lifespan to Understand Down syndromE) Predoctoral to Postdoctoral Fellow Transition Award (F99/K00), aimed at attracting exceptional graduate students to conduct research focused on Down syndrome. This funding opportunity supports up to 20 awards with a total commitment of $1.5 million for fiscal year 2025, providing six years of support divided between dissertation research (F99 phase) and mentored postdoctoral training (K00 phase). The initiative is crucial for advancing research that enhances the health and quality of life for individuals with Down syndrome, emphasizing the importance of mentorship and alignment with program goals. Interested applicants must ensure their applications align with one of the three research components and are encouraged to contact NIH Grants Information at grantsinfo@nih.gov for further inquiries, with applications due by July 1, 2026.

    Point(s) of Contact
    Files
    Title
    Posted
    The Department of Health and Human Services, through the National Institutes of Health (NIH), has issued a funding opportunity for the INCLUDE (INvestigation of Co-occurring conditions across the Lifespan to Understand Down syndromE) Predoctoral to Postdoctoral Fellow Transition Award (F99/K00). This initiative seeks to attract exceptional graduate students from various research fields to focus on Down syndrome research. The funding will support up to 20 awards with a commitment of $1.5 million in FY2025, providing a total of six years of support, split between dissertation research (F99 phase) and mentored postdoctoral training (K00 phase). Eligible applicants include domestic higher education institutions and organizations, but not foreign entities. The applications must be aligned with one of three research components aimed at improving the health and quality of life for individuals with Down syndrome. The transition from the F99 to K00 phase is contingent on the completion of the doctoral degree and securing a relevant postdoctoral position. The announcement emphasizes the importance of a robust application, highlighting mentorship and alignment with program goals. This opportunity not only fosters the academic growth of young scientists but also aims to advance research that can significantly impact public health regarding Down syndrome.
    Similar Opportunities
    INCLUDE Project: Transformative Research Awards for Down syndrome (R01 Clinical Trial Not Allowed)
    National Institutes of Health
    The National Institutes of Health (NIH) is offering the INCLUDE Project: Transformative Research Awards for Down syndrome, aimed at advancing innovative research to improve health and quality of life for individuals with Down syndrome. This funding opportunity invites applications for groundbreaking research that can establish new scientific paradigms or develop transformative technologies related to Down syndrome and its co-occurring conditions, with no preliminary data required. The program has an estimated total funding of $3 million, with individual awards ranging from $250,000 to $500,000, and is expected to support approximately four projects. Interested applicants can reach out to Dr. Charlene Schramm at schrammc@nih.gov or by phone at 301-402-3793, with applications due by February 19, 2026, and anticipated awards announced by September 1, 2026.
    INCLUDE Project: Exploratory/Developmental Research Awards for Down syndrome (R21 Clinical Trial Not Allowed)
    National Institutes of Health
    The National Institutes of Health (NIH) is offering the INCLUDE Project: Exploratory/Developmental Research Awards for Down syndrome, aimed at enhancing health and quality of life for individuals with Down syndrome. This funding opportunity invites researchers to propose innovative exploratory and developmental projects that address critical needs identified in the INCLUDE Project objectives, potentially leading to breakthroughs in biomedical, behavioral, or clinical research. The total estimated program funding is $1 million, with individual awards ranging from $50,000 to $200,000, and the application process is open to a diverse range of eligible applicants, including tribal governments and community-based organizations. Interested parties should contact Dr. Melissa Parisi at 301-728-1861 or via email at parisima@mail.nih.gov for further information, with applications due by February 19, 2026, and awards expected to be announced by September 1, 2026.
    INCLUDE Project: Clinical Trials Phased Awards for Down syndrome Research (R61/R33 Clinical Trial Required)
    National Institutes of Health
    The National Institutes of Health (NIH) is offering a funding opportunity through the INCLUDE Project, specifically for Clinical Trials Phased Awards aimed at advancing research on Down syndrome. This grant program encourages Exploratory/Developmental Phased Innovation (R61/R33) applications to develop clinical trials addressing critical health conditions associated with Down syndrome, with a focus on milestone-driven research. The total funding available for this initiative is approximately $3 million, with an expected four awards, and applications may request a minimum of $100,000. Interested applicants should note that the project period can extend up to five years, with the R61 phase supporting preliminary studies for up to two years, followed by a potential R33 phase for clinical trial support. For further inquiries, applicants can contact Laurie Ryan, PhD, at 301-496-9350 or via email at ryanl@nih.gov. The application deadline is set for February 19, 2026, with awards anticipated to be announced by September 1, 2026.
    Development of Animal Models and Related Biological Materials for Down Syndrome Research (R21 Clinical Trial Not Allowed)
    National Institutes of Health
    The National Institutes of Health (NIH) is offering a funding opportunity for exploratory research grants (R21) aimed at developing animal models and biological materials for Down syndrome (DS) research. This initiative, part of the INCLUDE Project, seeks to enhance understanding of co-occurring conditions associated with DS and improve health outcomes for affected individuals through innovative research. Eligible applicants, including higher education institutions, nonprofits, and local governments, can request up to $200,000 for a single year, with a total project period not exceeding two years. Interested parties should submit their applications by January 7, 2026, and can direct inquiries to NIH Grants Information at grantsinfo@nih.gov.
    Predoctoral to Postdoctoral Transition Award
    National Institutes of Health
    The National Institutes of Health (NIH) is offering the Predoctoral to Postdoctoral Transition Award (Parent F99/K00) to support promising graduate students as they complete their doctoral research training and transition into mentored postdoctoral career development opportunities in relevant research areas. This grant aims to retain talented individuals within the biomedical research workforce, aligning with the missions of participating NIH Institutes and Centers. The funding opportunity is categorized as discretionary, with no cost-sharing or matching requirements, and is open to small businesses. Interested applicants should note that the estimated synopsis post date is January 23, 2026, with a closing date of April 8, 2026, and the estimated award date is December 8, 2026. For further inquiries, applicants can contact the Division of Biomedical Research Workforce at NIH via email at nihtrain@mail.nih.gov or by phone at 301-451-0993.
    Development of Animal Models and Related Biological Materials for Down Syndrome Research (R21 Clinical Trials Not Allowed)
    National Institutes of Health
    The National Institutes of Health (NIH) has announced a funding opportunity titled "Development of Animal Models and Related Biological Materials for Down Syndrome Research" under the INCLUDE Project. This initiative aims to support exploratory and innovative research focused on developing and characterizing animal models and biological materials that are essential for Down syndrome (DS) studies, with an emphasis on improving access to these resources and enhancing the rigor of preclinical research. The funding opportunity is particularly significant as it addresses critical gaps in DS research, encouraging projects that utilize advanced technologies such as artificial intelligence and machine learning. Eligible applicants can receive up to $200,000 for a two-year project period, with applications due in March, June, October, and February each year, and the announcement set to expire on January 8, 2026. For further inquiries, interested parties can contact NIH Grants Information at grantsinfo@nih.gov.
    Omics Phenotypes Related to Down Syndrome for the INCLUDE Project (X01 Clinical Trial Not Allowed)
    National Institutes of Health
    The National Institutes of Health (NIH) has announced a Notice of Funding Opportunity (NOFO) titled "Omics Phenotypes Related to Down Syndrome for the INCLUDE Project (X01 Clinical Trial Not Allowed)." This initiative invites applications to utilize existing biospecimens to generate integrated genomic and multi-omics data aimed at uncovering the molecular mechanisms associated with health conditions related to Down syndrome. The program emphasizes the importance of including cohorts from underrepresented racial and ethnic groups and does not provide direct funding; instead, it facilitates access to sequencing resources for various genomic profiling techniques. Interested applicants should note that the earliest submission date is February 13, 2024, and they can reach out to NIH Grants Information at grantsinfo@nih.gov for further inquiries. More details can be found at the provided link: https://grants.nih.gov/grants/guide/pa-files/PAR-24-081.html.
    Advancing Research Careers (ARC) Predoctoral to Postdoctoral Transition Award to Promote Diversity (F99/K00 - Clinical Trial Not Allowed)
    National Institutes of Health
    The National Institutes of Health (NIH) is offering the Advancing Research Careers (ARC) Predoctoral to Postdoctoral Transition Award to Promote Diversity (F99/K00), aimed at supporting late-stage graduate students from diverse backgrounds in their transition to postdoctoral research positions. This two-phase grant program includes the F99 phase, which provides funding for 1-2 years to support doctoral dissertation projects, followed by the K00 phase, offering up to 3 years of mentorship in postdoctoral research. The initiative is designed to enhance diversity within the biomedical research workforce and encourages applicants to engage in mentoring and networking activities while outlining their commitment to inclusivity in their applications. Interested candidates must apply through Grants.gov, with the application deadline set for May 7, 2027. For further inquiries, applicants can contact NIH Grants Information at grantsinfo@nih.gov or visit the program's webpage at https://grants.nih.gov/grants/guide/pa-files/PAR-23-222.html.
    NIDCR Predoctoral to Postdoctoral Transition Award to Promote a Diverse Dental, Oral and Craniofacial Research Workforce (F99/K00 Independent Clinical Trial Not Allowed)
    National Institutes of Health
    The National Institutes of Health (NIH) is offering the NIDCR Predoctoral to Postdoctoral Transition Award (F99/K00) to promote a diverse workforce in dental, oral, and craniofacial research. This grant aims to support outstanding graduate students from underrepresented backgrounds as they transition from predoctoral to postdoctoral research training, facilitating their completion of PhD or dual-degree clinician scientist programs and progression to mentored postdoctoral positions. The program consists of two phases: the F99 phase provides up to two years of funding for PhD candidates, while the K00 phase offers up to three years of postdoctoral support, emphasizing the importance of diversity and inclusion in biomedical research. Interested applicants must adhere to specific eligibility criteria and can find additional details and application instructions at the provided NIH link, with the application deadline set for April 8, 2027.
    NINDS Alzheimers Disease-Related Dementias (ADRD) Advanced Postdoctoral Career Transition Award (K99/R00 Independent Clinical Trial Not Allowed)
    National Institutes of Health
    The National Institutes of Health (NIH) is offering the NINDS Alzheimer's Disease-Related Dementias (ADRD) Advanced Postdoctoral Career Transition Award (K99/R00), aimed at supporting emerging independent researchers transitioning from mentored postdoctoral positions to tenure-track faculty roles in ADRD research. This grant program seeks to cultivate a diverse pool of skilled scientists by providing up to two years of mentored support followed by a three-year independent phase, contingent on securing a faculty position, while emphasizing research that does not involve leading independent clinical trials. The initiative aligns with the National Plan to Address Alzheimer’s Disease, focusing on enhancing research capabilities to combat cognitive decline and dementia. Interested applicants must adhere to eligibility criteria, including a maximum of four years of postdoctoral experience, and can find further details and application deadlines, which span from September 2024 to December 2026, at the provided NIH link. For inquiries, contact NIH Grants Information at grantsinfo@nih.gov.